HSV-1 vs HSV-2: What Is the Difference?

HSV-1 and HSV-2 are both herpes simplex viruses, but they differ in ways that significantly affect transmission routes, recurrence rates, and clinical management. HSV-1 primarily infects the oral region and causes cold sores, is transmitted through kissing and oral contact, and now accounts for more than 50% of new genital herpes diagnoses in young adults through oral sex; HSV-2 is the primary cause of genital herpes, is transmitted through genital skin-to-skin contact, recurs more frequently genitally than HSV-1, and causes asymptomatic shedding in 87% of infected people who may not know they carry the virus.

The Core Biology: Why They Behave Differently

HSV-1 and HSV-2 are closely related alphaherpesviruses that share approximately 83% genetic homology, but they differ in which anatomical location they prefer for neurological latency. HSV-1 has a neurotropic preference for the trigeminal ganglion, which serves the face, lips, and oral cavity. This is why HSV-1 most naturally establishes latency at the oral site and recurs there. HSV-2 has a neurotropic preference for the sacral dorsal root ganglia (S2-S4), which serve the genitals, buttocks, and inner thighs. This is why HSV-2 recurs genitally much more frequently than at oral sites. The site preference isn't absolute: HSV-1 can infect the genitals (through oral sex) and HSV-2 can infect the oral area, but both viruses recur far less frequently when established at their non-preferred anatomical site. Genital HSV-1 recurs approximately 1 to 2 times per year on average, compared to genital HSV-2 which averages 4 to 6 recurrences in the first year. Oral HSV-2, conversely, recurs infrequently — a fact that is clinically useful for counseling.

Transmission: Different Routes, Overlapping Risk

HSV-1 transmission: primarily through oral-to-oral contact — kissing, sharing utensils or drinks, skin-to-skin facial contact. The vast majority of HSV-1 infections are acquired in childhood through contact with infected adults. In adults, HSV-1 genital infection occurs through oral sex (fellatio or cunnilingus performed by someone who orally sheds HSV-1). Asymptomatic oral shedding of HSV-1 occurs on approximately 9 to 18% of days in infected people, which means transmission occurs without a visible cold sore being present. HSV-2 transmission: through genital skin-to-skin contact, including intercourse and rubbing. HSV-2 is not efficiently transmitted through oral contact — a person who performs oral sex on a partner with genital HSV-2 has a relatively low risk of acquiring oral HSV-2, because the trigeminal ganglion is not the preferred latency site. The epidemiological shift: over the past two decades, oral sex has become the dominant route of genital herpes acquisition in young adults in high-income countries, primarily because HSV-1 seropositivity in childhood has declined (less early-life oral exposure, better hygiene), leaving young adults susceptible to HSV-1 through oral-genital contact.

Clinical Symptoms: Similarities and Differences

Primary infection with either type can cause significant illness: painful genital or oral lesions, systemic fever and malaise (more common with primary HSV-2 genital infection), lymphadenopathy, and dysuria in genital cases. The acute presentations are largely indistinguishable clinically without PCR type identification. Where they differ is in recurrence. Genital HSV-2: median recurrence rate of 4 to 6 per year in the first year, gradually declining over subsequent years in most people. Genital HSV-1: median recurrence rate approximately 1 to 2 per year, often diminishing rapidly. After 5 to 10 years, many people with genital HSV-1 have essentially no outbreaks. Oral HSV-1 (cold sores): variable recurrence, triggered by UV exposure, febrile illness, stress, immunosuppression; can be frequent in some individuals. This recurrence difference is clinically important: knowing the herpes type helps set realistic expectations and guides the decision about whether to start suppressive antiviral therapy.

Asymptomatic Shedding: Where the Transmission Risk Lives

Both types shed asymptomatically between outbreaks, but at different rates. HSV-2 genital shedding: approximately 15 to 20% of days, with shedding episodes typically lasting a few hours. HSV-1 genital shedding: approximately 5% of days — significantly lower than HSV-2 at the same site. Oral HSV-1 shedding: 9 to 18% of days. These rates mean that genital HSV-2 carriers have a higher ongoing transmission risk than genital HSV-1 carriers, even with no symptoms and comparable outbreak frequencies.

Testing: Why Type Identification Matters

Type-specific HSV IgG testing (HerpeSelect or equivalent) identifies whether antibodies are present to HSV-1, HSV-2, or both. A positive HSV-1 IgG in most adults doesn't tell you where the infection is — most positive HSV-1 results reflect oral herpes from childhood exposure, not genital infection. A positive HSV-2 IgG is more specifically associated with genital infection. PCR typing from an active lesion definitively identifies the type and site, which is the most clinically useful test for someone with an active outbreak. Knowing the type changes counseling: a person with genital HSV-1 and their partner should be told the recurrence and shedding rates differ significantly from genital HSV-2, and that the transmission risk from genital HSV-1 is lower.

For type-specific HSV IgG and PCR testing with results in 1 to 2 days, Health Test Express offers herpes panels without a GP referral.

When to Seek Evaluation

Get tested if: you have active lesions that could be herpes (PCR swab gives the most accurate type-specific result); you've been told you have herpes but don't know the type (type identification changes recurrence expectations and management); you have a new partner and want to know your baseline herpes serostatus; you're pregnant with a partner known to have genital herpes (type and timing matter for neonatal transmission risk counseling).

Frequently Asked Questions

Is HSV-1 or HSV-2 worse?

Genital HSV-2 is associated with more frequent recurrences and higher asymptomatic shedding than genital HSV-1, which makes it clinically more challenging to manage. Oral HSV-1 (cold sores) affects a larger proportion of the global population and is widely normalized, though it carries real transmission risk. Neither is inherently "worse" as a systemic medical condition — both are manageable chronic infections.

Can you have both HSV-1 and HSV-2?

Yes. Dual infection with both types is common, particularly in people with high sexual exposure risk. Prior HSV-1 infection provides partial cross-immunity to HSV-2 acquisition — studies show prior HSV-1 seropositivity reduces the risk of acquiring symptomatic HSV-2 infection by approximately 30 to 40%, though not to zero.

If I have oral HSV-1, can I give my partner genital herpes?

Yes. Performing oral sex while asymptomatically shedding HSV-1 can transmit the virus to a partner's genitals. This is now the primary route of new genital herpes infections in young adults. The risk is present even without an active cold sore, because asymptomatic shedding occurs on approximately 9 to 18% of days.

Does HSV-1 go away on its own?

Individual cold sore outbreaks resolve within 1 to 2 weeks without treatment. The virus itself does not go away — it establishes permanent latency in the trigeminal ganglion. Suppressive antiviral therapy (acyclovir or valacyclovir daily) reduces oral outbreak frequency significantly for people with frequent cold sores.

Related: Herpes symptoms HSV-2 · First signs of herpes · How is herpes spread? · Can herpes go away on its own? · Get tested today

This article is for informational purposes only and does not constitute medical advice.